Table 1.
Characteristics of the entire patient cohort
| Variable | Analysis procedure | Validated procedure | ||||
|---|---|---|---|---|---|---|
|
| ||||||
| GRG | GSG | P value | GRG | GSG | P value | |
| No. subjects | 9 | 9 | - | 37 | 39 | - |
| Sex (M/F) | 5/4 | 4/5 | 0.50a | 17/20 | 21/18 | 0.32a |
| Age (years) | 40.66±14.45 | 41.11±14.92 | 0.95b | 43.51±13.39 | 42.64±12.88 | 0.69b |
| Mayo score | 9.44±2.12 | 9.67±1.32 | 0.79b | 9.59±1.77 | 9.31±2.00 | 0.24b |
| EBV-DNA | 125.97±220.93 | 73.78±117.52 | 0.29b | 41.64±97.62 | 44.18±106.41 | 0.99b |
| CMV-DNA | 20.52±39.42 | 14.68±25.83 | 0.53b | 30.99±65.78 | 33.62±68.59 | 0.80b |
GRG: glucocorticoids resistant group, GSG: glucocorticoids sensitive group, M: male, F: female. Age, Mayo score, EBV-DNA and CMV-DNA were presented as mean ± standard deviation (x̅ ± s), EBV-DNA and CMV-DNA were E+2.
a
Pearson Chi-Square;
b
Independent sample-t test.